News & Media

News
March 1, 2023
Andelyn Biosciences Board of Directors Announce New CEO
READ MORE
News
March 1, 2023
Andelyn Biosciences Board of Directors Announce New CEO
(COLUMBUS, Ohio) – Andelyn Biosciences Chief Operations Officer Wade Macedone has been promoted to CEO of the gene and cell...
News
February 1, 2023
Andelyn Biosciences and Odylia Therapeutics Partner to Manufacture Novel Gene Therapy for Vision Loss
Novel AAV Capsid Anc80 enables efficient gene transfer COLUMBUS, OH, 31st JANUARY, 2023 – Andelyn Biosciences, Inc., a pioneering and...
Media Release
January 13, 2022
FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development
COLUMBUS, OH, January 13, 2022 – Andelyn Biosciences, a pioneering cell and gene therapy CDMO born out of Nationwide Children’s Hospital, today...
Media Release
August 25, 2021
Andelyn Biosciences Selects TetraScience as a Strategic Partner for Innovation in Therapeutics Development and Manufacturing
TetraScience, the R&D Data Cloud company, announced today that Andelyn Biosciences, Inc. has selected the Tetra Data Platform (TDP) to build a cloud-native development and manufacturing service for its customers.
Media Release
March 18, 2021
Nationwide Children’s Hospital Affiliate Andelyn Biosciences Receives Significant Investment and Enters Into Strategic Partnership with Pall Corporation and Cytiva
COLUMBUS, Ohio – Andelyn Biosciences, Inc, a contract development and manufacturing organization (CDMO) and an affiliate company of Nationwide Children’s Hospital, has...
Media Release
November 25, 2020
Andelyn Biosciences Breaks Ground for New Commercial-Scale Gene Therapy Manufacturing Facility
COLUMBUS, Ohio – Andelyn Biosciences, an affiliate company of Nationwide Children’s Hospital that manufactures gene therapy products for the biotechnology and pharmaceutical...